Schedule 13G ownership disclosure

VERRICA PHARMACEUTICALS INC

Common Stock, $0.0001 par value per share · CUSIP: 92511W207

Event date: 2025-11-25

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Affinity Asset Advisors, LLC

    Shares: 884,172 · Class: 5.47%

  • Affinity Healthcare Fund, LP

    Shares: 884,172 · Class: 5.47%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001011438-25-000591
Form type
SCHEDULE 13G
Filer
Affinity Asset Advisors, LLC
CIK
CIK 1773195
Filed
Dec 03, 2025
Reporting period
Nov 25, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub